Mabpharm Limited, a Taizhou, Jiangsu Province-based biotechnology company, has filed for an initial public offering in Hong Kong, becoming the latest Chinese biotech firm rushing for a Hong Kong IPO. (more…)
CDH Investments-backed Chinese Biotechnology Firm Mabpharm Files For Hong Kong IPO appeared first on China Money Network.